08.01.2020 SHOP APOTHEKE EUROPE N.V.  NL0012044747

DGAP-News: Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE.


 

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel
Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE.

08.01.2020 / 09:57
The issuer is solely responsible for the content of this announcement.


Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE.

Venlo/Cologne, 8 January, 2020. Jasper Eenhorst will become the new Chief Financial Officer of SHOP APOTHEKE EUROPE N.V. effective February 1, 2020. The 47-year-old Dutchman previously held several finance and management positions at internationally leading food retailer Ahold Delhaize. Most recently he was CFO for the rapidly growing e-commerce unit of top Dutch supermarket chain Albert Heijn B.V.

At SHOP APOTHEKE EUROPE Eenhorst will be responsible for the classic Finance functions as well as for Investor Relations and areas of Compliance. CEO Stefan Feltens will be in charge of Strategy, HR, Legal, Procurement and Corporate Communications.

"In Jasper Eenhorst we gain a renowned financial expert who also has substantial experience and success in the digital business arena", says SHOP APOTHEKE EUROPE Supervisory Board Chairman Jan Pyttel. "Jasper played an important role in building and expanding the e-commerce business of the Netherlands' leading supermarket chain Albert Heijn in his previous position."

CEO Stefan Feltens adds: "We are excited that Jasper will soon be strengthening our Management Board and are delighted to welcome him to our team. With his expertise and international experience, he'll be able to significantly contribute to further strengthening SHOP APOTHEKE EUROPE's growth course."

"I am looking forward to leveraging my e-commerce experience for the benefit of SHOP APOTHEKE EUROPE", says Jasper Eenhorst. "The online pharmacy segment is growing rapidly and as one of Europe's market leaders, SHOP APOTHEKE EUROPE is ideally positioned to increasingly exploit its potential.

In accordance with Dutch law, Jasper Eenhorst will be proposed to be appointed as a member of the Management Board by the next Annual General Meeting of SHOP APOTHEKE EUROPE N.V.

MEDIA CONTACTS.

Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 465 31317

Bettina Fries
Tel: +49 211 75 80 779

Email: presse@shop-apotheke.com

Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: carmen.herkenrath@shop-apotheke.com

 



08.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: carmen.herkenrath@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 948861

 
End of News DGAP News Service

948861  08.01.2020 

fncls.ssp?fn=show_t_gif&application_id=948861&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2013 2014 2015 2016 2017 2018 2019 2020e
Umsatzerlöse1 55,29 84,67 125,58 177,39 283,99 539,71 701,01 939,00
EBITDA1,2 -0,75 -2,39 -6,65 -8,84 -12,14 -15,56 -18,58 20,30
EBITDA-Marge3 -1,36 -2,82 -5,30 -4,98 -4,27 -2,88 -2,65 2,16
EBIT1,4 -1,88 -4,05 -8,82 -11,64 -19,20 -28,73 -33,45 0,00
EBIT-Marge5 -3,40 -4,78 -7,02 -6,56 -6,76 -5,32 -4,77 0,00
Jahresüberschuss1 -2,83 -5,04 -10,58 -18,45 -21,36 -33,61 -36,27 0,00
Netto-Marge6 -5,12 -5,95 -8,42 -10,40 -7,52 -6,23 -5,17 0,00
Cashflow1,7 -4,24 -3,68 -8,78 -17,21 -23,24 -23,54 -30,37 0,00
Ergebnis je Aktie8 -0,31 -0,56 -1,16 -2,03 -2,25 -2,79 -2,78 -0,70
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2019 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Shop Apotheke Europe
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2AR94 149,600 Halten 2.676,37
KGV 2021e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,000 -90,83
KBV KCV KUV EV/EBITDA
8,94 - 3,82 -145,973
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
0,00 0,00 0,00 30.04.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
14.05.2020 06.08.2020 05.11.2020 17.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,03% 54,06% 241,16% 298,40%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SHOP APOTHEKE EUROPE N.V.  ISIN: NL0012044747 können Sie bei DGAP abrufen

E-Commerce , A2AR94 , SAE , XETR:SAE